
| Serial Number | 90242675 |
| Word Mark | DENDREON |
| Filing Date | Thursday, October 8, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, July 6, 2021 |
| Registration Number | 6408163 |
| Registration Date | Tuesday, July 6, 2021 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, April 20, 2021 |
| Description of Mark | The mark consists of the term "Dendreon" having a capital "D" and lowercase "endreon" in combination with a design element, the design element consisting of two discrete parts located above the adjacent letters "e," "o," and "n," the first part being a feather shape having two pointed ends, the upper side of which is formed by a convex arc, and the lower side of which is formed by an elongated sine wave shape, resulting in the left side of the feather being thin and quill-shaped, and the right side of the feather being wider and rounder, the whole of the feather-shaped first part extending from the left side of the "e" slightly upward to the right side of the "o"; and the second part of the design element consisting of the x-axis mirror image of the first part, located to its right, such that the upper side of the feather-shaped second part is formed by an elongated cosine wave shape and the lower side is formed by a concave arc, with the whole of the feather-shaped second part extending from the left side of the "o" slightly upward to the right side of the "n," resulting in the right half of the feather-shaped first part overlapping with the left half of the feather-shaped second part. |
| Goods and Services | Antibacterial pharmaceuticals; Antibacterial substances for medical purposes; Cells for medical or clinical use; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Intravenous bags sold filled with sipuleucel-T; Pharmaceutical preparations for the treatment and prevention of cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Pharmaceutical preparations for cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the treatment of cancer; Pharmaceuticals, namely, anti-infectives; Therapeutic pharmaceutical for the treatment of cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Living cells for medical use; Pharmaceutical preparations for the treatment of infectious diseases |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, November 24, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | Thursday, April 29, 2010 |
| First Use In Commerce Date | Thursday, April 29, 2010 |
| Party Name | Dendreon Pharmaceuticals LLC |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Seal Beach, CA 90740 |
| Party Name | Dendreon Pharmaceuticals LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Seal Beach, CA 90740 |
| Party Name | Dendreon Pharmaceuticals LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Seal Beach, CA 90740 |
| Event Date | Event Description |
| Monday, October 12, 2020 | NEW APPLICATION ENTERED |
| Tuesday, November 24, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, November 25, 2020 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Monday, March 8, 2021 | ASSIGNED TO EXAMINER |
| Friday, March 12, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 31, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 20, 2021 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 20, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 6, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, April 20, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, April 20, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, April 20, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, December 4, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, December 4, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, December 4, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, December 4, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, December 4, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, December 4, 2024 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED |
| Wednesday, December 4, 2024 | WITHDRAWAL OF ATTORNEY GRANTED |